
Marconi Abreu MD
Diabetes, Lipid Metabolism
Medical Director Parkland Endocrinology Clinic
Join to view full profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-2800
Fax+1 214-645-8697
Dr. Abreu is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Marconi Abreu, MD, based in Dallas, TX, specializes in endocrinology with subspecialties in diabetes and lipid metabolism. He completed his medical degree at the Federal University of Bahia Faculty of Medicine in 2002, followed by an internal medicine residency at the University of Connecticut from 2004 to 2007, and a fellowship in endocrinology, diabetes, and metabolism at the University of Texas Southwestern Medical Center from 2012 to 2015. Dr. Abreu is experienced in managing diabetes mellitus, obesity and associated disorders, lipid metabolism disorders, osteoporosis, and polycystic ovarian syndrome. He has contributed to several publications on topics such as glucagon-like-peptide-1 receptor agonist therapy, automated insulin delivery systems, incretin-based therapies, and glucose monitoring systems in hospitalized patients, with some of these works cited multiple times. Dr. Abreu also actively participates in clinical trials, including the SIMPLE study on insulin titration and liraglutide for type 2 diabetes.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2012 - 2015
University of ConnecticutResidency, Internal Medicine, 2004 - 2007
Federal University of Bahia Faculty of MedicineClass of 2002
Certifications & Licensure
TX State Medical License 2014 - 2028
MA State Medical License 2008 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
Publications & Presentations
PubMed
- Contemporary Initial Glucose-Lowering Strategies for Type 2 Diabetes: A Systematic Review and Bayesian Network Meta-Analysis.Gabriel Cavalcante Lima Chagas, Mayara Rios Leite Macedo Monteiro, Marina Loch Eira, Gaspar R Chiappa, Joaquim Silva Custódio Jr
Diabetes, Obesity & Metabolism. 2026-12-01 - Pulmonary response to glucagon-like peptide-1 receptor agonist therapy in adults with cystic fibrosis-related diabetes: factors associated with improvement in FEV.Sasan Mirfakhraee, Marconi Abreu, Akruti Singh, Gregory A Ratti, James D Finklea
Respiratory Medicine. 2026-11-01 - Adjunctive use of glucagon-like peptide-1 receptor agonists after bariatric surgery: updated systematic review and meta-analysis of randomized controlled trials.Sakshi Arora, Fnu Amna, Fatemeh Akbarpoor, Dhvanit Rajdeep, Muhammad Khalid
Acta Diabetologica. 2026-11-01
Press Mentions
UTSW Endocrinologists Find Paralysis Disorder May Be Underdiagnosed Among Hispanic MenMay 8th, 2023
News Highlights - February 3, 2026February 6th, 2026
Effective Use of Continuous Glucose Monitoring in Type 1 DiabetesMarch 29th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: